Close Menu

sequencing-based diagnostics

NEW YORK (GenomeWeb News) – Ariosa Diagnostics announced today that it has inked a partnership with Advance Medical to offer its Harmony Prenatal Test to clinicians in Mexico.

NEW YORK (GenomeWeb News) – OncoDNA today said that it will collaborate with the Integrated BioBank of Luxembourg to provide physicians in Luxembourg with access to next-generation sequencing-based testing for cancer.

NEW YORK (GenomeWeb News) – BioReference Laboratories said today that it will acquire certain assets of Edge Biosystems, a reagents and sequencing services company.

This article has been updated with a comment from one of the researchers regarding which tests will be included in the study.

NEW YORK (GenomeWeb News) – Sequenom today said that its San Diego lab, the Sequenom Center for Molecular Medicine, has received a clinical laboratory permit from New York Department of Health's Wadsworth Center Clinical Laboratory Evaluation Program.

NEW YORK (GenomeWeb News) – Life Technologies and RainTree Oncology Services today announced a collaborative agreement to bring advances in molecular testing to the broader patient market while developing a streamlined protocol for bringing patients into clinical trials for targeted therapies.

NEW YORK (GenomeWeb News) – Illumina announced late Thursday that Verinata Health has received a clinical laboratory permit from the State of New York for its laboratory, allowing the company to market its Verifi non-invasive prenatal diagnostic test in the state.

NEW YORK (GenomeWeb News) – Sequenom and CombiMatrix today announced an agreement to market chromosomal microarray analysis testing services "to broaden and confirm the results of non-invasive prenatal testing" to doctors and patients.

NEW YORK (GenomeWeb News) – Life Technologies announced today a five-year deal with the US Food and Drug Administration aimed at detecting E. coli and Salmonella.

NEW YORK (GenomeWeb News) – MolecularMD today announced a licensing deal covering DDR2 mutations for lung cancer.

Pages

NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.

Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.

In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.